10 drug(s) with this reaction
3,453 total reports
Chest Pain has been reported as an adverse reaction across 10 drug(s) manufactured by Amgen Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 3,453 adverse event reports mention chest pain in connection with Amgen Inc products.
This page provides a breakdown of which Amgen Inc drugs are most commonly associated with chest pain, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Amgen Inc drugs have chest pain listed in their FDA adverse event reports, sorted by report count:
In addition to chest pain, the following adverse reactions have been reported across Amgen Inc's drug portfolio:
10 drug(s) manufactured by Amgen Inc have chest pain listed in their FDA adverse event reports: DENOSUMAB, PEGFILGRASTIM, DARBEPOETIN ALFA, FILGRASTIM, EPOETIN ALFA, and others.
There are a combined 3,453 reports of chest pain across 10 Amgen Inc drug(s) in the FDA adverse event database.